fullerene c60 has been researched along with glutamic acid in 5 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (glutamic acid) | Trials (glutamic acid) | Recent Studies (post-2010) (glutamic acid) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 41,757 | 452 | 12,876 |
| Protein | Taxonomy | fullerene c60 (IC50) | glutamic acid (IC50) |
|---|---|---|---|
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Metabotropic glutamate receptor 8 | Homo sapiens (human) | 0.0057 | |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.07 | |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor 1 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor 2 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor 3 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 0.38 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 207 | |
| Glutamate receptor 4 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1533 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WQ; Chiang, LY; Jin, H; Schloss, JV; Tang, XW; Wu, JY; Yang, CY | 1 |
| Bianco, A; Briand, JP; Hoebeke, J; Pantarotto, D; Prato, M | 1 |
| Bar-Shir, A; Basso, AS; Costa-Pinto, FA; Engel, Y; Frenkel, D; Gozin, M; Monsonego, A; Petrovic-Stojkovic, S; Puckett, L; Quintana, FJ; Weiner, HL | 1 |
| Albasanz, JL; Bonifazi, D; Delforge, A; Giust, D; Marega, R; Martín, M | 1 |
| Albasanz, JL; Da Ros, T; Giust, D; Martín, M | 1 |
5 other study(ies) available for fullerene c60 and glutamic acid
| Article | Year |
|---|---|
Polyhydroxylated C(60), fullerenols, as glutamate receptor antagonists and neuroprotective agents.
Topics: Animals; Binding Sites; Brain; Calcium; Carbon; Cell Death; Cells, Cultured; Chlorides; Excitatory Amino Acid Antagonists; Female; Ferric Compounds; Fetus; Free Radical Scavengers; Fullerenes; Glutamic Acid; Hydrogen Peroxide; Intracellular Fluid; Nerve Degeneration; Neurons; Neuroprotective Agents; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, GABA; Receptors, Glutamate; Receptors, Neurotransmitter | 2000 |
Solid-phase synthesis and characterization of a novel fullerene-peptide derived from histone H3.
Topics: Chromatography, High Pressure Liquid; Epitopes; Fullerenes; Glutamic Acid; Histones; Models, Molecular; Molecular Structure; Peptides; Protein Structure, Tertiary | 2003 |
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
Topics: Amino Acid Transport System X-AG; Animals; Astrocytes; Axons; B-Lymphocytes; CD11b Antigen; Chemokine CCL2; Chronic Disease; Disease Models, Animal; Disease Progression; Fullerenes; Glutamic Acid; Memory; Mice; Molecular Structure; Multiple Sclerosis; Oxidative Stress; T-Lymphocytes | 2008 |
[60]Fullerene-based monolayers as neuroprotective biocompatible hybrid materials.
Topics: Biocompatible Materials; Cell Line, Tumor; Coordination Complexes; Fullerenes; Glutamic Acid; Gold; Humans; Neurons; Neuroprotective Agents | 2011 |
Modulation of gene expression of adenosine and metabotropic glutamate receptors in rat's neuronal cells exposed to L-glutamate and [60]fullerene.
Topics: Analysis of Variance; Animals; Cells, Cultured; Cerebral Cortex; Fullerenes; Gene Expression; Glutamic Acid; Neurons; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Metabotropic Glutamate; Receptors, Purinergic P1 | 2014 |